INVEGA TRINZA® delivers sustained plasma concentrations1,2
No correlation to clinical effect
Due to the difference in median pharmacokinetic profiles between the 2 products (INVEGA TRINZA® [paliperidone palmitate] and INVEGA SUSTENNA® [paliperidone palmitate]), caution should be exercised when making a direct comparison of their pharmacokinetic properties.2
INVEGA TRINZA® provides a dosing interval that can be measured in seasons, not days1
With 3 months in between doses of INVEGA TRINZA®, your patients can spend less time having medication conversations and more time focusing on other aspects of their treatment plan.